4 results match your criteria: "Mayo Clinic and Mayo Foundation for Medical Education and Research[Affiliation]"
Editorial Cycles and Continuity of Diabetes Care.
Diabetes Care
July 2022
New York Regional Center for Diabetes Translational Research, Albert Einstein College of Medicine, Bronx, NY.
Factors Determining the Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3.
Arthritis Rheumatol
July 2016
Mayo Clinic and Mayo Foundation for Medical Education and Research, Rochester, Minnesota.
Objective: Relapse following remission is common in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), particularly with ANCAs directed at proteinase 3 (PR3). This study was undertaken to evaluate the association of an increase in PR3-ANCA level with subsequent relapse.
Methods: Data from the Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis (RAVE) trial were used.
Evidence for ordering of Alzheimer disease biomarkers.
Arch Neurol
December 2011
Department of Radiology, Mayo Clinic and Mayo Foundation for Medical Education and Research, 200 First St, SW, Rochester, MN 55905, USA.
Objective: To empirically assess the concept that Alzheimer disease (AD) biomarkers significantly depart from normality in a temporally ordered manner.
Design: Validation sample.
Setting: Multisite, referral centers.
Incidence and clinical characteristics of childhood glaucoma: a population-based study.
Arch Ophthalmol
April 2010
Medical School, Mayo Clinic College of Medicine, Mayo Clinic and Mayo Foundation for Medical Education and Research, Rochester, Minnesota 55905, USA.
Objective: To describe the incidence and clinical characteristics of childhood glaucoma in a defined population of the United States.
Methods: The medical records of all pediatric patients younger than 20 years living in Olmstead County, Minnesota, from January 1, 1965, through December 31, 2004, who met diagnostic criteria for glaucoma or glaucoma suspect were reviewed.
Results: Thirty children were diagnosed as having glaucoma during the 40-year study period.